The contribution of binge eating (BE) behaviour to cardiometabolic risk factors has been scarcely investigated so far. Previous studies have not considered the nutritional status and lifestyle of subjects suffering from BE. The aim of this study was to evaluate the contribution of BE to the metabolic syndrome (MS), its components, high total cholesterol and high LDL in a large sample of subjects, taking into account nutritional status, dietary habits, smoking status and physical activity. For this purpose, 5175 adults seeking a weight loss or maintenance programme were recruited. Anthropometrical measurements and blood parameters were measured. BE was evaluated using the Binge Eating Scale (BES). A fourteen-item questionnaire was used to evaluate the adherence to the Mediterranean diet. Smoking status and physical activity were investigated by interview. BE prevalence was 0·16 (95 % CI 0·15, 0·17). A sex-and age-adjusted Poisson regression model showed a higher prevalence of MS in binge eaters (0·33; 95 % CI 0·28, 0·37) compared with non-binge eaters (0·27; 95 % CI 0·25, 0·28, P = 0·011). However, the statistical difference was lost after inclusion of BMI and lifestyle parameters in the multiple-adjusted model. We also evaluated the association between the continuous outcomes of interest and the BES score using a multivariable median regression model. We observed a positive, but clinically irrelevant, association between BES score and HDL levels (P < 0·001). In conclusion, BE does not seem to be independently related to cardiometabolic risk factors. However, the screening and treatment of BE are of clinical relevance in order to reduce the risk of developing obesity.
Binge eating (BE) is a behaviour characterised by eating in a discrete period of time an amount of food that is definitely larger than what most people would eat in a similar period of time under similar circumstances, accompanied by a sense of lack of control over eating. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (1) , when such behaviour occurs at least once weekly for 3 months without compensatory behaviours, it is defined as binge eating disorder (BED). BE is also common in other eating disorders such as bulimia nervosa (BN), some subtypes of anorexia nervosa (AN) and eating disorders not otherwise specified (EDNOS) (1) . It is particularly prevalent in subjects seeking a weight loss or maintenance programme, among whom BE prevalence is 17 %, with increased prevalence in women as well as in younger and in obese subjects (2) . Beyond the higher risk of developing obesity, binge eaters have a worse dietary pattern (3) , a higher smoking status (4) and lower physical activity levels than subjects free of BE (2) .
Obesity and lifestyle are crucial factors associated with cardiometabolic diseases (5, 6) , whereas the contribution of BE behaviour is still a debated topic (7) . A 5-year longitudinal study of 134 individuals with BED compared with age-and sex-matched controls (the authors tried to match even for BMI, but failed in their purpose) showed an increased risk for dyslipidemia in subjects with BED, after adjusting for sex, age, baseline BMI and BMI changes. The authors concluded that BED might confer a risk of components of the metabolic syndrome (MS) over and above the risk attributable to obesity alone (8) . Subsequently, a cross-sectional study carried out on 3551 participants of the Framingham Heart Study reported that subjects with objective BE, but not subjects with subclinical BE, had a higher risk of impaired fasting glucose compared with non-binge eaters, after adjusting for sex, age, BMI, smoking status, alcohol intake, education and depressive symptoms (9) . A further cross-sectional study carried out on 2225 patients waiting for bariatric surgery reported a positive association between BED status and impaired fasting glucose, after controlling for age, sex, education, BMI and psychiatric disorders (10) . More recently, a 16-year longitudinal study observed a higher incidence of type 2 diabetes mellitus in subjects with BED and BN, but not AN, compared with age-and sex-matched controls (11) . All these evidences suggest that BE may increase the likelihood of developing components of MS (7) . Nevertheless, whether this increased risk is attributable to an independent contribution of BE or to a higher presence of obesity and unhealthy lifestyle is unclear (7) . Previous studies, indeed, have not taken, or only partially taken, into account the effects of nutritional status and lifestyle on cardiometabolic risk factors. Therefore, the relative contribution of BE to cardiometabolic risk is presently unknown.
In this context, the aim of this study was to evaluate the contribution of BE to cardiometabolic risk in a large sample of subjects starting a weight loss or maintenance programme, taking into account the potential effects of nutritional status, dietary habits, smoking status and physical activity.
Methods

Study design
We performed a cross-sectional study on 5466 consecutive adults who self-referred to the International Center for the Assessment of Nutritional Status (University of Milan) from September 2010 to January 2015, in order to participate in a structured weight loss or weight maintenance programme. On the same day, they underwent a clinical examination, an anthropometric assessment and a structured interview by a trained dietitian, in order to obtain information about marital status, educational level, smoking status and structured physical activity. Physical activity was investigated by asking the subjects the following questions: 'Do you practice any structured physical activity?' and 'How many hours per week do you spend on this activity?'. Subjects who spent ≥2 h/week performing any structured physical activity were considered as active (2) . Moreover, all the patients filled in two questionnaires to evaluate adherence to the Mediterranean diet (12, 13) and the presence of BE (14, 15) . From the initial number of subjects recruited for the study, thirty subjects were excluded because they were diagnosed as having acute infective, neurological, gastrointestinal, cardiac, renal and pulmonary disorders or were unable to understand and fill in the questionnaires. The present study was carried out according to the Declaration of Helsinki, and all participants gave their written informed consent to participate. The institutional review board approved the study procedures.
Anthropometric measurements
Anthropometric measurements were obtained according to conventional criteria and measuring procedures proposed by Lohmann et al. (16) . Body weight (BW, kg) was measured using Column scale (Seca 700 balance; Seca Corporation) up to 100 g with subjects wearing only light underwear and after bladder emptying. Body height (BH, cm) was measured to the nearest 0·1 cm using a vertical stadiometer. BMI was calculated using the following formula: BMI (kg/m . Waist circumference was measured midway between the lower rib margin and the superior anterior iliac spine to the nearest 0·5 cm with a non-stretch tape applied horizontally.
Laboratory measurements
Fasting total cholesterol, HDL-cholesterol, LDL-cholesterol, TAG and glucose were measured using enzymatic methods (Cobas Integra 400 Plus; Roche Diagnostics) (17) . Blood pressure was measured by a physician using a random-zero mercury sphygmomanometer following the Joint National Committee 7 guidelines (18) .
The metabolic syndrome and clinical outcomes
The MS was diagnosed using the harmonised international definition (19) . Large waist was defined as waist circumference ≥102 cm in men and ≥88 cm in women, low HDL-cholesterol as values <40 mg/dl in men and <50 mg/dl in women, high TAG as values ≥150 mg/dl or treatment with TAG-lowering drugs, high blood pressure as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or treatment with pressurelowering drugs, and high glucose as values ≥100 mg/dl or treatment with glucose-lowering drugs. The MS was defined as three or more of the above components. In addition, high total cholesterol was defined as total cholesterol ≥200 mg/dl and high LDL as values ≥130 mg/dl.
Mediterranean dietary pattern
Adherence to the Mediterranean diet was evaluated using a validated fourteen-item questionnaire (13) , which is the extension of an original nine-item questionnaire (12) . A fourteenitem Mediterranean score (Medscore) was obtained from this questionnaire following the guidelines of the PREvención con DIeta MEDiterránea (PREDIMED) study (www.predimed.es) and a specific validation study by Schroder et al. (13) with some adaptations already used in previous studies (3, (20) (21) (22) . In brief, 1 point was attributed for each of the following: (1) olive oil as the main cooking fat, (2) olive oil ≥4 tablespoons/d, (3) vegetables ≥2 servings/d (≥1 portion raw or on salad), (4) fruits ≥3 servings/d, (5) red or processed meat <1 serving/d, (6) butter or cream or margarine <1/d, (7) soda drinks <1/d, (8) wine ≥3 glasses/week, (9) legumes ≥3 servings/week, (10) fish/seafood ≥3 servings/week, (11) commercial sweets and confectionery <3/week, (12) nuts ≥1/week, (13) white more than red meats (yes) and (14) use of sofrito sauce ≥2/week. Subjects with a MEDscore ≥9 points were considered to have a high adherence to the Mediterranean diet (3, 21, 22) .
Psychological assessment
Eating behaviour was evaluated using the Italian version of the Binge Eating Scale (BES) (14, 15) . BES consists of sixteen forced-choice questions, each with a set of three to four answer choices. BES gives a score ranging from 0 to 46. BE was defined as a BES score ≥18 (23) . The questionnaire was considered invalid when more than 10 % of items was missing. Following such criteria, further 261 subjects were excluded.
Statistical analysis
Statistical analyses were performed on a final number of 5175 subjects. Most continuous variables had non-Gaussian distributions, and all are reported as 25th, 50th and 75th percentiles. Discrete variables are reported as counts and frequencies.
A Poisson working regression model (PWRM) with robust 95 % CI was used to estimate prevalence and its predictors (24, 25) . A PWRM was used because a binomial regression model failed to converge for some of the regressions of interest. Expectedly, the estimates made by the binomial regression model and by the PWRM were similar in all cases where both converged. Sex-and age-adjusted and multiple-adjusted PWRM were used to evaluate the associations of MS, its components, high cholesterol and high LDL with BES. The response variable of all PWRM (MS, MS components, high cholesterol, low LDL) was discrete (0 = no; 1 = yes). Besides BES (discrete, 0 = non-binge eater; 1 = binge eater, or continuous, score units), predictors of the multivariable PWRM were the following: (1) sex (discrete, 0 = female; 1 = male), (2) age (continuous, years/10), (3) BMI (continuous, kg/m 2 ), (4) Medscore (continuous, score units), (5) smoking status (discrete, 0 = no; 1 = ex; 2 = yes) and (6) physical activity (discrete, 0 = no; 1 = yes). Adjusted probabilities of the responses of interest were calculated from the PWRM (26) . We also evaluated the association between the continuous MS components (TAG, HDL, glucose, systolic blood pressure and diastolic blood pressure), total cholesterol and LDLcholesterol and the BES score using a multivariable median regression model (MRM) using the same covariates of the PWRM -that is, sex, age, BMI, Medscore, smoking status and physical activity. Adjusted estimates of the responses of interest were calculated from the MRM (26) .
Degree 2 multivariable fractional polynomials (MFP) were used to test whether the relationships of continuous predictors with the responses were non-linear (27) . MFP selected an inverse square root transformation of BMI for all PWRM models and no transformation, a log e transformation, an inverse transformation or an inverse square-root transformation for age depending on the model. There was only a modest gain in the linearity of continuous predictors when MFP were applied to the MRM; therefore, all continuous covariates were kept untransformed for the MRM analysis. Adjusted estimates of the responses of interest were calculated from the MRM (26) .
Statistical analyses were performed using Stata 14.2 (Stata Corporation LP).
Results
The continuous measurements of the 5175 study subjects are given in Table 1 . Women made up 72 % of the study population.
The distribution of age, BMI status, BE, MS and lifestyle factors is given in Table 2 .
The prevalence of BE in the pooled sample was 0·16 (95 % CI 0·15, 0·17) and was higher in women (0·20; 95 % CI 0·19, 0·21) than in men (0·07; 95 % CI 0·06, 0·08, P < 0·001, PWRM).
The prevalence and prevalence rate ratios (PRR) of MS, its components, high total cholesterol and high LDL-cholesterol are given in Table 3 .
The prevalence of MS in the pooled sample was 0·28 (95 % CI 0·26, 0·29). This prevalence was higher in binge eaters (0·33; 95 % CI 0·28, 0·37) compared with non-binge eaters (0·27; 95 % CI 0·25, 0·28) in the sex-and age-adjusted model (P = 0·011, PWRM). However, the statistical difference was lost after inclusion of nutritional status and lifestyle factors in the multiple-adjusted model. The prevalence of high blood pressure was marginally higher in binge eaters (0·52; 95 % CI 0·47, 0·57) compared with non-binge eaters (0·47; 95 % CI 0·45, 0·49) in the sex-and age-adjusted model (P = 0·076, PWRM). However, the statistical difference was lost after inclusion of nutritional status and lifestyle factors in the multiple-adjusted model. No differences in the prevalence of high TAG, low HDL, high glucose, high total cholesterol and high LDL were observed between binge eaters and non-binge eaters in both models. Table 4 reports the PRR of MS, its components, high total cholesterol and high LDL associated with an increase of 1 unit in the BES score in the sex-and age-adjusted model and in the multiple-adjusted model (sex, age, BMI, Medscore, smoking status and physical activity).
We observed an increased risk in MS, high blood pressure and high glucose associated with an increase of 1 unit in the BES score in the sex-and age-adjusted model. However, such increments were no more significant in the multiple-adjusted model. Only a weak inverse association was observed between the BES score and the risk of low HDL. Fig. 1 plots the prevalence of MS, its components, high cholesterol and high LDL as a function of continuous BES, taking into account the effects of sex, age, BMI, Medscore, smoking status and physical activity (PWRM, see the 'Statistical analysis' section for details). The values graphed on the x-axis represent the 5th, 25th, 50th, 75th and 95th percentiles of the BES score. Fig. 2 plots the median values of TAG, total cholesterol, HDL, LDL, glucose, systolic blood pressure and diastolic blood pressure as a function of continuous BES, taking into account the effects of sex, age, BMI, Medscore, smoking status and physical activity (MRM, see the 'Statistical analysis' section for details). The values graphed on the x-axis represent the 5th, 25th, 50th, 75th and 95th percentiles of the BES score. The association with BES was linear in all cases and was statistically significant only for HDL, which was higher in patients with BE (P < 0·001).
Discussion
This is the first study to explore, in a large sample, the association between BE and cardiometabolic risk factors, taking into account the effects of nutritional status and lifestyle.
Our study confirms that BE is common in patients seeking a weight loss or maintenance programme, with higher prevalence in women than in men (2) . Moreover, we found an increased risk of MS, high blood pressure and high glucose with increasing BES scores in the sex-and age-adjusted model. However, such associations were lost after inclusion of nutritional status and lifestyle factors in the model. Only an inverse, but clinically irrelevant, association was found between BES score and low HDL risk. These results are of great relevance in order to better understand the independent contribution of BE to cardiometabolic risk. The present study, indeed, adds to the information that BE is unlikely related to MS and other metabolic parameters. On the basis of such findings, and on previous evidences suggesting an association between BE and obesity, low adherence to the Mediterranean diet (3) , a higher smoking status (4) and low physical activity level (2) , we can speculate that BE leads to MS through the development of obesity and of an unhealthy lifestyle. However, only a longitudinal trial can confirm such a speculation. Previous case-control studies, carried out on small samples of obese patients with BED, have not found any significant difference in binge eating episodes or severity of eating disorder psychopathology between subjects with and without MS (28, 29) . Nevertheless, Roehrig et al. (28) found that some lifestyle behaviours including fewer episodes of weight cycling and regular meal skipping were significant predictors of MS. However, Blomquist et al. (29) failed to replicate these findings, adding that dietary restraint, depressive symptoms or self-esteem did not differ between subjects with and without MS. A non-significant association between BE and MS has also been reported in two cross-sectional studies (9, 10) and in a longitudinal study (8) . In agreement with these studies, we did not find any increased risk of MS with increasing BE severity after inclusion of nutritional status and lifestyle factors.
Even though the two cross-sectional studies involving subjects of the Framingham Heart Study (9) and patients waiting for bariatric surgery (10) did not find any association between BE and MS, they observed a higher risk of impaired fasting glucose in subjects with BED compared with subjects without BED, after adjustment for nutritional status and other potential confounders. However, they did not adjust for important lifestyle factors such as dietary pattern and physical activity, and this could be the reason for the discrepancy between the results. In fact, we observed that the initial significant association between BES score and the risk of impaired fasting glucose was lost after adjusting for nutritional status and lifestyle factors. These considerations may also explain why our findings are inconsistent with results reported by Raevuori et al. (11) and de Jonge et al. (30) . These two studies, using, respectively, a longitudinal (11) and cross-sectional design (30) , observed an increased risk of type 2 diabetes mellitus in subjects with BED and BN. However, BMI and lifestyle data were not available, and therefore all analyses were not adjusted for nutritional status and other confounders. Moreover, as the authors stated, subjects with BED were more prone to develop overweight and obesity (11) . These strong limitations do not allow to establish whether the increased risk of diabetes is attributable to BE or to a worse nutritional status. In contrast, a longitudinal study, carried out on a small sample of overweight and obese individuals, reported a higher 5-year incidence of dyslipidemia in subjects with BED compared with age-and sex-matched controls after adjustment for nutritional status (8) . Even though this study is worthy for its longitudinal design, it has the strong limitation of using selfreported metabolic values, which may be less accurate, and thus the quantification of associations would have been less reliable. Moreover, they did not take into account any variable describing the lifestyle of individuals, and, for example, a lower physical activity level and a higher sedentary lifestyle, which are behaviours typical in subjects with BED (31) , may be the reasons for the higher risk of dyslipidemia. Our findings show an increment in serum HDL levels with increasing BES scores. However, the difference was small and clinically irrelevant. In fact, it should be noted that the difference in the serum level of HDL-cholesterol between BES scores corresponding to the 5th and 95th percentiles was only approximately 3·5 mg/dl. Multiple-adjusted model  0·99  0·99, 1·00  0·99  0·98, 1·00  0·99**  0·98, 1·00  1·00  0·99, 1·00  1·00  0·99, 1·01  1·00  1·00, 1·00  1·00  0·99, 1·01 Medscore, Mediterranean score. ** P < 0·01, *** P < 0·001. † The multiple-adjusted model included sex, age, BMI, Medscore, smoking status and physical activity as covariates.
Strengths of this study include its sample size and the fact that we are the first to adjust the analysis for nutritional status and lifestyle variables such as adherence to the Mediterranean diet, smoking status and physical activity. Moreover, we decided to include normal weight subjects as well, as we recently showed that this category of individuals, especially young women, is not BE-free (2) . However, it is not free of limitations. First, its cross-sectional nature does not allow us to establish a cause-effect relationship. Second, we enrolled subjects seeking a weight loss or maintenance programme, and therefore our results cannot be extrapolated to the general population. Third, we did not have any information concerning the onset of binging. Finally, we focused on BE, the primary diagnostic criterion for several disorders including BED, BN, AN and EDNOS, whose presence, however, does not necessarily involve the presence of an objective eating disorder.
In conclusion, BE does not seem to confer a risk of MS and other metabolic parameters over and above the risk attributable to obesity and lifestyle alone. However, considering the higher risk for developing obesity and having an unhealthy lifestyle among subjects suffering from BE, the screening and treatment of BE are issues of clinical relevance for the prevention of obesity and cardiometabolic diseases.
